Gland Pharma (NSE:GLAND, BOM:543245) appointed Deepak Sapra as its new chief executive officer, effective Nov. 16.
Sapra currently serves as CEO of API and Services at Dr. Reddy's Laboratories (NSE:DRREDDY, BOM:500124), according to an Indian bourse filing on Friday.
Shares of the company rose over 1% in recent trade.